These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 36686467)
41. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis. Geron Y; Benbassat C; Shteinshneider M; Or K; Markus E; Hirsch D; Levy S; Ziv-Baran T; Muallem-Kalmovich L Thyroid; 2019 Apr; 29(4):513-522. PubMed ID: 30799769 [TBL] [Abstract][Full Text] [Related]
42. Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma. Shin CH; Roh JL; Song DE; Cho KJ; Choi SH; Nam SY; Kim SY Am J Surg; 2020 Oct; 220(4):925-931. PubMed ID: 32081409 [TBL] [Abstract][Full Text] [Related]
43. Predictive factors for nodal recurrence in differentiated thyroid cancers. Kaur J; Nadarajan A; Janardhan D; George NA; Thomas S; Varghese BT; Krishna J Cancer Treat Res Commun; 2023; 36():100728. PubMed ID: 37336036 [TBL] [Abstract][Full Text] [Related]
44. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study. Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795 [TBL] [Abstract][Full Text] [Related]
45. Bilateral papillary thyroid cancer and associated histopathologic findings. Hwang E; Pakdaman MN; Tamilia M; Hier MP; Black MJ; Rochon L; Payne RJ J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):284-7. PubMed ID: 20470673 [TBL] [Abstract][Full Text] [Related]
46. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma. Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062 [TBL] [Abstract][Full Text] [Related]
47. The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis. Wu ZJ; Xia BY; Chen ZW; Gong H; Abuduwaili M; Xing ZC; Su AP Front Endocrinol (Lausanne); 2023; 14():1217613. PubMed ID: 37745721 [TBL] [Abstract][Full Text] [Related]
48. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011 [TBL] [Abstract][Full Text] [Related]
49. Loss of CDH16 expression is a strong independent predictor for lymph node metastasis in Middle Eastern papillary thyroid cancer. Siraj AK; Parvathareddy SK; Al-Rasheed M; Annaiyappanaidu P; Siraj N; Lennartz M; Al-Sobhi SS; Al-Dayel F; Sauter G; Al-Kuraya KS Sci Rep; 2023 Oct; 13(1):18559. PubMed ID: 37899424 [TBL] [Abstract][Full Text] [Related]
50. Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe. Kim SY; Kim SM; Chang H; Kim BW; Lee YS; Chang HS; Park CS ANZ J Surg; 2019 Nov; 89(11):E498-E501. PubMed ID: 31566299 [TBL] [Abstract][Full Text] [Related]
51. The synergic effect of BRAF Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763 [TBL] [Abstract][Full Text] [Related]
52. The impact of the multifocality and subtypes of papillary thyroid carcinoma on central compartment lymph node metastasis. Soylu L; Aydin OU; Ozbas S; Bilezikci B; Ilgan S; Gursoy A; Kocak S Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3972-3979. PubMed ID: 27775804 [TBL] [Abstract][Full Text] [Related]
53. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases]. Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234 [TBL] [Abstract][Full Text] [Related]
54. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior. Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652 [TBL] [Abstract][Full Text] [Related]
55. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan. Zaman SU; Awan MS; Sulaiman MA Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545 [TBL] [Abstract][Full Text] [Related]
56. Optimal Surgical Extent in Patients with Unilateral Multifocal Papillary Thyroid Carcinoma. Woo J; Kwon H Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053595 [TBL] [Abstract][Full Text] [Related]
57. Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients. Lu Y; Jiang L; Chen C; Chen H; Yao Q Medicine (Baltimore); 2020 Apr; 99(15):e19795. PubMed ID: 32282744 [TBL] [Abstract][Full Text] [Related]
58. Clinical Implication of Bilateral and Unilateral Multifocality in Papillary Thyroid Carcinoma: A Propensity Score-Matched Study. Kim Y; An S; Park J; Bae JS; Kim JS; Kim K Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509259 [TBL] [Abstract][Full Text] [Related]
59. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer? Elbasan O; Ilgın C; Gogas Yavuz D Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491 [TBL] [Abstract][Full Text] [Related]